The adjustment in price target by Wedbush reflects a slight modification in their valuation assessment of Xencor, likely due to updated analysis or market conditions. However, maintaining an Outperform rating indicates a continued positive outlook on the company's performance. This mixed signal could lead to neutral short-term price movement as investors digest the implications of a lower price target with a still positive rating.